CHMP Grants Positive Opinion for Expanded Use of Darzalex®▼ (daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone (VTd) for Patients with Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible
- EMEA Innovative Medicine
- CHMP Grants Positive Opinion for Expanded Use of Darzalex®▼ (daratumumab)
CHMP Grants Positive Opinion for Expanded Use of Darzalex®▼ (daratumumab)
- X (Twitter)
Copy link